Deepull · Series C

Barcelona medical diagnostics company developing UllCORE, a rapid direct-from-blood

Amount

$56M

Round

Series C

Valuation

—

Announced

—

Investors

Participating investors

Columbus Venture Partners Asabys Partners Merieux Equity Partners Panakes Partners Kurma Partners